Andie Collier, MSc

Ms. Collier has served as our Chief Regulatory and Quality Affairs Officer since March 2023. She joined Galera as Senior Vice President, Regulatory Affairs in August 2021.

Ms. Collier has over twenty-five years of regulatory affairs and quality experience with drugs, biologics, medical devices, and drug/device combination, encompassing a broad understanding of phase I-IV clinical trials development and management ranging from feasibility to commercial marketing. She has worked on over 80 successful INDs and 60 NDAs with the FDA, in oncology, dermatology and cardiology divisions. She has also shepherded several regulatory approvals in Europe, Australia, Latin America, Japan, and other Asian regulatory agencies. Ms. Collier was most recently the Senior Vice President of Regulatory Affairs, US, Europe and Global New Molecular Entities at Glenmark Pharmaceuticals and held positions of increasing executive experience in several biopharma companies, including Gilead, BTG, Johnson & Johnson and Merck.

Ms. Collier is a pharmacist with a post-graduate specialization in Industrial and Hospital Pharmacy and holds a MSc in Regulatory Affairs from the University of Southern California.